share_log

Benchmark Reiterates Buy on Tenon Medical, Maintains $6 Price Target

Benzinga ·  Mar 10, 2023 23:47

Benchmark analyst Jackson Ader reiterates Tenon Medical (NASDAQ:TNON) with a Buy and maintains $6 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment